Association of CD34 Cell Dose with 5-Year Overall Survival after Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies.
Transplant Cell Ther
; 28(2): 88-95, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-34774817
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Hematologic Neoplasms
/
Graft vs Host Disease
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Transplant Cell Ther
Year:
2022
Document type:
Article
Country of publication:
Estados Unidos